Hydrochlorothiazide; Olmesartan Medoxomil Patent Expiration
Hydrochlorothiazide; Olmesartan Medoxomil is Used for managing high blood pressure. It was first introduced by Cosette Pharmaceuticals Inc
Hydrochlorothiazide; Olmesartan Medoxomil Patents
Given below is the list of patents protecting Hydrochlorothiazide; Olmesartan Medoxomil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Benicar Hct |
US6878703 (Pediatric) | Pharmaceutical composition |
May 19, 2022
(Expired) | Cosette |
| Benicar Hct | US6878703 | Pharmaceutical composition |
Nov 19, 2021
(Expired) | Cosette |
| Benicar Hct |
US5616599 (Pediatric) | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Oct 25, 2016
(Expired) | Cosette |
| Benicar Hct | US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Apr 25, 2016
(Expired) | Cosette |
Hydrochlorothiazide; Olmesartan Medoxomil's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List